Showing 5271-5280 of 20465 results for "".
- The Role of Diet in Modulating Cardiovascular Gene Activityhttps://reachmd.com/news/the-role-of-diet-in-modulating-cardiovascular-gene-activity/2484543/A controlled trial found that daily consumption of 100% orange juice for two months altered immune-cell transcriptomes linked to cardiovas
- Enhancing Wound Care: Piper nigrum in Collagen Dressingshttps://reachmd.com/news/wound-care-piper-nigrum-collagen-dressings/2484535/Piper nigrum extract integrated into collagen wound dressings offers a targeted antimicrobial adjunct for infected and chronic wounds, reducing microbial burden while preserving material biocompatibility. In a
- PSMA Theranostics: Expanding Horizons in Oncologyhttps://reachmd.com/news/psma-theranostics-expanding-horizons-in-oncology/2484540/PSMA theranostics have reshaped prostate cancer care by pairing sensitive localization with lesion-directed radioligand therapy, improving detection and enabling targeted systemic treatment. PS
- Lumenis Debuts Stellar M22™ with XPL™ at ASDS 2025, Showcases Single-Session Clearance Datahttps://reachmd.com/news/lumenis-debuts-stellar-m22-with-xpl-at-asds-2025-showcases-single-session-clearance-data/2484554/Lumenis Be. Ltd. introduced the next-generation Stellar M22™ with XPL™ Technology during the 2025 Annual American Society for Dermatologic Surgery (ASDS) Meeting, highlighting single-session clearance rates of up to 100% for vascular and pigmented lesions. The multi-application aesthetic platform
- NIH Grants for Vitiligo Research Rise Over Time, Driven by Medical Schools and NIAMShttps://reachmd.com/news/nih-grants-for-vitiligo-research-rise-over-time-driven-by-medical-schools-and-niams/2484513/Funding trends National Institutes of Health (NIH) funding trends shows steady, long-term support for vitiligo research from 1985 through 2024, according to a new analysis. Using the NIH Research Portfolio Online Reporting To
- Navigating the H3N2 Challenge: Strategies for Primary Care this Flu Seasonhttps://reachmd.com/news/navigating-the-h3n2-challenge-strategies-for-primary-care-this-flu-season/2484515/An emerging H3N2 influenza variant is now dominant, raising the risk of a more severe flu season. The variant shows antigenic drift from this season’s vaccine strains, modestly
- 3D Printing and Personalized Medicine: Ketoprofen Tablets as a Case Studyhttps://reachmd.com/news/3d-printing-and-personalized-medicine-ketoprofen-tablets-as-a-case-study/2484528/In a recent study, fused deposition modeling (FDM) 3D printing produced ketoprofen tablets that delivered both immediate‑release and sustained‑release profiles from a single manufacturing platform, supporting on‑demand, point‑of‑care p
- Advancing Melanoma Diagnostics: AI and Digital Pathology Synergyhttps://reachmd.com/news/advancing-melanoma-diagnostics-ai-and-digital-pathology-synergy/2484521/A recent MDPI review found that AI-enabled digital pathology is improving melanoma diagnostic accuracy and reshaping pathology workflows. Narrative syntheses summarize comparative perfor
- The Role of Sleep Consistency in Hypertension Managementhttps://reachmd.com/news/sleep-consistency-hypertension-management/2484525/An Oregon Institute of Occupational Health Sciences study found that maintaining consistent bedtimes produced measurable reductions in bot
- Allergan Aesthetics Celebrates Seventh Annual BOTOX® Cosmetic Dayhttps://reachmd.com/news/allergan-aesthetics-celebrates-seventh-annual-botox-cosmetic-day/2484512/Allergan Aesthetics, an AbbVie company, marks the seventh annual BOTOX® Cosmetic Day on Wednesday, November 19, 2025. The yearly celebration honors patients and providers who have contributed to the longevity and success of the injectable treatment, which remains the top-selling product in its ca